Surgical debridement devices are medical instruments used to remove dead tissue, foreign matter, and infectious agents from wounds, facilitating healing and reducing complications. These tools are critical in managing chronic wounds, trauma, and post-surgical recovery. The Surgical Debridement Devices market size is projected to grow at a CAGR of 6.8% from 2026 to 2033, driven by rising chronic disease prevalence, advancements in wound care technologies, and expanding healthcare infrastructure. The industry expansion is further fueled by regulatory approvals and increased adoption of minimally invasive procedures. As of 2026, the market is estimated to reach USD 425 million, reflecting its strategic relevance in global surgical care.